Be the first to review this item
Cerepro (Cholini alfosceras, Choline alfoscerate) - central holinostimulyator, in which the composition contains 40.5% metabolically protected choline (metabolic protection promotes the release of choline in the brain). When ingested, it is cleaved by the action of enzymes in the glycerophosphate choline and choline is involved in the biosynthesis of acetylcholine - one of the major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neuronal membrane. Provides phosphatidylcholine and acetylcholine synthesis in neuronal membranes, improves blood flow and increases the metabolic processes in the central nervous system and activates the reticular formation. Increases blood flow linear velocity on the side of a traumatic brain injury, it promotes the normalization of the space-time characteristics of spontaneous bioelectric activity of the brain; It has a positive effect on the cognitive and behavioral responses in patients with cerebrovascular diseases.
Cerepro improves brain function, affecting the pathogenetic factors of involutional psychoorganic syndrome alters neuronal membrane phospholipid composition and reduces the cholinergic activity. Dose-dependently stimulates the release of acetylcholine; participating in the synthesis fosfagidilholina (membrane phospholipid) improves synaptic transmission, neuronal plasticity membrane receptor function. No effect on the reproductive cycle and does not have teratogenic and mutagenic effect.
In acute conditions: intramuscularly or intravenously (slowly) 1.0 g (1 ampoule) per day for 10-15 days, then move on to the capsules inside of 0.8 g (2 capsules) in the morning and 0.4 g (1 capsule) day for 6 months.
Allergic reactions, nausea (due to dopaminergic activation).
Important notice- the outer box design may vary before prior notice!